Utilization and Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Predictive Molecular Biomarker (BMX) Tests
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.012
https://www.valueinhealthjournal.com/article/S1098-3015(17)30346-7/fulltext
Section Title :
BREAKOUT SESSION II
Section Order :
8
First Page :
A400
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30346-7&doi=10.1016/j.jval.2017.08.012